XYLB — XY Labs Income Statement
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- $22.12m
- $20.17m
- $13.17m
Annual income statement for XY Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 21.6 | 11.6 | 7.61 | 13.2 |
| Cost of Revenue | ||||
| Gross Profit | 16 | 5.24 | 5.86 | 12.5 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 31.6 | 21.6 | 12.7 | 15 |
| Operating Profit | -10 | -9.94 | -5.04 | -1.87 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2.53 | -8.96 | -5.06 | 5.6 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.53 | -8.96 | -5.04 | 5.06 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.53 | -8.96 | -5.04 | 5.06 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -2.53 | -8.96 | -5.04 | 5.06 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.141 | -0.164 | -0.114 | 0.001 |
| Dividends per Share |